Clinical Trial Update: d68Ga-DOTATATE PET/CT Assessment of Cardiac Sarcoidosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating d68Ga-DOTATATE PET/CT for assessing cardiac sarcoidosis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Sarcoidosis

Drugs mentioned

• d68Ga-DOTATATE (dotatate)

Snippet

Sponsor: Mayo Clinic | Conditions: Cardiac Sarcoidosis | Phase 4 | Status: COMPLETED | Results posted: 2020-10-20